Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
The AKT protein kinase plays a central role in several interconnected molecular pathways involved in growth, apoptosis, angiogenesis, and cell metabolism. It thereby represents a therapeutic target, especially in hormone receptor-positive (HR) breast cancers, where the PI3K/AKT signaling pathway is...
Main Authors: | Benoîte Mery, Coralie Poulard, Muriel Le Romancer, Olivier Trédan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/24/13512 |
Similar Items
-
Modern combined targeted and immunotherapy of metastatic skin melanoma
by: S. A. Protsenko, et al.
Published: (2020-12-01) -
A Novel Class of Elicitin-like Genes from Phytophthora infestans
by: Sophien Kamoun, et al.
Published: (1997-11-01) -
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
by: Coralie Poulard, et al.
Published: (2023-08-01) -
Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: Pharmacophore, virtual screening, and MD simulation techniques
by: Hafiz Muhammad Ahmad, et al.
Published: (2022-08-01) -
Comparative Phenotypic, Proteomic, and Phosphoproteomic Analysis Reveals Different Roles of Serine/Threonine Phosphatase and Kinase in the Growth, Cell Division, and Pathogenicity of <i>Streptococcus suis</i>
by: Qiao Hu, et al.
Published: (2021-11-01)